Innovating Works

IZMIR BIOMEDICINE AND GENOME CENTER

Desconocido
ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE IZMIR BIYOTIP VE GENOM MERKEZI participó en un HORIZON EUROPE HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado
CHIRON: The role of the non-canonical death receptor signalling in cancer and immune cells IZMIR BIYOTIP VE GENOM MERKEZI tramitó un HORIZON EUROPE HORIZON-MSCA-2022-SE-01 Immune surveillance refers to the ability of the immune system to efficiently induce cell death (apoptosis) in aberrant cells during the ear...
2023-10-01 - 2027-09-30 | Financiado
CHIRON: The role of the non-canonical death receptor signalling in cancer and immune cells IZMIR BIYOTIP VE GENOM MERKEZI tramitó un HORIZON EUROPE HORIZON-MSCA-2022-SE-01 Immune surveillance refers to the ability of the immune system to efficiently induce cell death (apoptosis) in aberrant cells during the ear...
2023-06-26 - 2027-09-30 | Financiado
halt-RONIN: Discovering chronic inflammation biomarkers that define key stages in the Healthy to NASH non alcoh... IZMIR BIYOTIP VE GENOM MERKEZI participó en un HORIZON EUROPE HORIZON-HLTH-2022-STAYHLTH-02 Non-alcoholic fatty liver disease (NAFLD) is a multifactorial chronic inflammatory disease that is prevalent in 1 of 4 individuals with a si...
2022-11-22 - 2026-11-30 | Financiado
RareBoost: Boosting the Rare Disease research and innovation capacity of the Izmir Biomedicine and Genome Cente... IZMIR BIYOTIP VE GENOM MERKEZI tramitó un H2020 H2020-WIDESPREAD-2018-2020 Although diseases afflicting less than 1 person in 2000 are defined as rare diseases, the approx. 6000 different rare diseases together caus...
2020-06-10 - 2026-09-30 | Financiado
CLEAN: Well Confined Mucosal LasEr Ablation with a Negative Pressure Based Endoscopy Capsule IZMIR BIYOTIP VE GENOM MERKEZI tramitó un H2020 H2020-MSCA-IF-2018 This proposal is an interdisciplinary research action. The objective of the CLEAN project is to develop a novel endoscopic capsule design an...
2019-03-22 - 2021-03-31 | Financiado
DISCOVER: Death receptor signalling in tumour immune editing IZMIR BIYOTIP VE GENOM MERKEZI participó en un H2020 H2020-MSCA-RISE-2017 During tumour development there is a bi-directional communication between cancer cells and immune cells; the process termed tumour immune ed...
2017-10-25 - 2022-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.